RECRUITING

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Official Title

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis: Translating Guidelines of Care to Better Outcomes for Patients With Psoriatic Disease

Quick Facts

Study Start:2023-06-15
Study Completion:2025-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05908240

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Willing and able to provide informed consent
  2. 2. Male or female aged 40-75
  3. 3. Being seen by a dermatology provider in routine care for the primary encounter diagnosis of psoriasis
  1. 1. Currently taking a prescription lipid lowering medication
  2. 2. Pregnant or planning pregnancy in the next 6 months
  3. 3. Has a known history of cardiovascular disease (MI, Stroke, coronary artery, cerebrovascular, or peripheral vascular disease)

Contacts and Locations

Study Contact

Brooke Bishop, MPH
CONTACT
267-581-9714
Brooke.Bishop@pennmedicine.upenn.edu

Study Locations (Sites)

Johnson Dermatology
Fort Smith, Arkansas, 72916
United States
Dawes Fretzin Clinical Research
Columbus, Indiana, 47201
United States
Dawes Fretzin Clinical Research
Indianapolis, Indiana, 46250
United States
MiSkinCenter
Northville, Michigan, 48167
United States
SUNY Downstate
Brooklyn, New York, 11203
United States
City Dermatology
Bensalem, Pennsylvania, 19020
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
University of Utah
Salt Lake City, Utah, 84112
United States
University of Virginia
Charlottesville, Virginia, 22903
United States
Bellevue Dermatology Clinic
Bellevue, Washington, 98004
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-15
Study Completion Date2025-10

Study Record Updates

Study Start Date2023-06-15
Study Completion Date2025-10

Terms related to this study

Additional Relevant MeSH Terms

  • Psoriasis
  • Psoriatic Arthritis
  • Psoriatic Conditions
  • Cardiovascular Diseases